The introduction of a direct-to-clinics sales division and prescribing system by MangoRx is likely to enhance the company's market penetration in the healthcare sector. By enabling doctors to prescribe MangoRx products directly from their practices, the company could see an increase in product usage and sales. This strategic move is expected to positively impact MangoRx's short-term stock performance as it could lead to increased revenue and market share in the healthcare industry.